| Name | serine peptidase inhibitor, Kunitz type, 2 |
| Description | This gene encodes a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serine proteases. The protein inhibits HGF activator which prevents the formation of active hepatocyte growth factor. This gene is a putative tumor suppressor, and mutations in this gene result in congenital sodium diarrhea. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSPINT2, also known as hepatocyte growth factor activator inhibitor type‐2 (HAI‐2), is a Kunitz‐type serine protease inhibitor that plays a critical role in regulating pericellular proteolysis. By inhibiting key activators such as the hepatocyte growth factor activator (HGFA) and membrane‐bound proteases including matriptase and prostasin, SPINT2 modulates the HGF/MET signaling cascade and thereby influences cell–cell interactions, migration, and invasion. This precise proteolytic control is essential for maintaining normal tissue homeostasis and preventing aberrant protease activities that may otherwise trigger pathological processes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMultiple studies have identified SPINT2 as a tumor suppressor whose loss or inactivation—commonly through promoter hypermethylation or deleterious mutations—leads to the deregulation of pivotal proteolytic networks. In various malignancies, including renal cell carcinoma, medulloblastoma, hepatocellular carcinoma, esophageal squamous cell carcinoma, and prostate and ovarian cancers, decreased SPINT2 expression is associated with enhanced protease activity, increased tumor cell motility, invasion, and metastatic potential. Restoration of SPINT2 expression, whether by genetic re-expression or pharmacological demethylation, is shown to curb these aggressive cellular behaviors by reining in the HGF/MET pathway and its downstream signaling cascades."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "32"}]}, {"type": "t", "text": "\n\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its tumor‐suppressive functions, SPINT2 is also implicated in congenital disorders and the regulation of developmental and physiological processes. Mutations in SPINT2 are causative of syndromic forms of congenital sodium diarrhea and congenital tufting enteropathy, conditions marked by disrupted epithelial barrier function and unrestrained protease activity. Moreover, SPINT2 contributes to the proper functioning of diverse tissues such as the placenta and testis, and modulates extracellular protease–inhibitor interactions within the tumor microenvironment. Epigenetic regulation of SPINT2, alongside its potential restoration by demethylating agents, underscores its promise as a therapeutic target across a spectrum of pathophysiological states."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "33", "end_ref": "44"}]}, {"type": "t", "text": "\n\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Christian Parr, Gareth Watkins, Robert E Mansel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The hepatocyte growth factor regulatory factors in human breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.ccr-0553-3"}], "href": "https://doi.org/10.1158/1078-0432.ccr-0553-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14734471"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14734471"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "H Kataoka, T Shimomura, T Kawaguchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2000)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M006412200"}], "href": "https://doi.org/10.1074/jbc.M006412200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11013244"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11013244"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Mark R Morris, Dean Gentle, Mahera Abdulrahman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-04-3371"}], "href": "https://doi.org/10.1158/0008-5472.CAN-04-3371"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15930277"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15930277"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Roman Szabo, John P Hobson, Karin List, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M801970200"}], "href": "https://doi.org/10.1074/jbc.M801970200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18713750"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18713750"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Peter Heinz-Erian, Thomas Müller, Birgit Krabichler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in SPINT2 cause a syndromic form of congenital sodium diarrhea."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2009.01.004"}], "href": "https://doi.org/10.1016/j.ajhg.2009.01.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19185281"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19185281"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Paul N Kongkham, Paul A Northcott, Young Shin Ra, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-2169"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-2169"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19047176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19047176"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Julie Salomon, Olivier Goulet, Danielle Canioni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-013-1380-6"}], "href": "https://doi.org/10.1007/s00439-013-1380-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24142340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24142340"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mika Suzuki, Hiroshi Kobayashi, Yoshiko Tanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.10950"}], "href": "https://doi.org/10.1002/ijc.10950"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12569552"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12569552"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Kenichi Fukai, Osamu Yokosuka, Tetsuhiro Chiba, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14695180"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14695180"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "C-H Tsai, C-H Teng, Y-T Tu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.412"}], "href": "https://doi.org/10.1038/onc.2013.412"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24121274"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24121274"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Mika Suzuki, Hiroshi Kobayashi, Yoshiko Tanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bikunin target genes in ovarian cancer cells identified by microarray analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M300239200"}], "href": "https://doi.org/10.1074/jbc.M300239200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12571229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12571229"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Wenjie Dong, Xiaobing Chen, Jing Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.25161"}], "href": "https://doi.org/10.1002/ijc.25161"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20063316"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20063316"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Keiichiro Nakamura, Atsushi Hongo, Junichi Kodama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.25606"}], "href": "https://doi.org/10.1002/ijc.25606"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20715109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20715109"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Hang Su, Jing Zhao, Yujuan Xiong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mutat Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mrfmmm.2008.02.005"}], "href": "https://doi.org/10.1016/j.mrfmmm.2008.02.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18358501"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18358501"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Hiroshi Kobayashi, Mika Suzuki, Naohiro Kanayama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Biochem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1432-1033.2002.03068.x"}], "href": "https://doi.org/10.1046/j.1432-1033.2002.03068.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12180971"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12180971"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Kiyoshi Wakahara, Hiroshi Kobayashi, Tatsuo Yagyu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bikunin suppresses lipopolysaccharide-induced lethality through down-regulation of tumor necrosis factor- alpha and interleukin-1 beta in macrophages."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Infect Dis (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/428134"}], "href": "https://doi.org/10.1086/428134"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15717269"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15717269"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Keiichiro Nakamura, Fernando Abarzua, Junichi Kodama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2009)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19148468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19148468"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Christopher Bergum, Karin List "}, {"type": "b", "children": [{"type": "t", "text": "Loss of the matriptase inhibitor HAI-2 during prostate cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pros.21177"}], "href": "https://doi.org/10.1002/pros.21177"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20687215"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20687215"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Charlotte Mizon, Frank Piva, Viviane Queyrel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urinary bikunin determination provides insight into proteinase/proteinase inhibitor imbalance in patients with inflammatory diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chem Lab Med (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/CCLM.2002.100"}], "href": "https://doi.org/10.1515/CCLM.2002.100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12211652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12211652"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Mika Suzuki, Hiroshi Kobayashi, Michio Fujie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M108545200"}], "href": "https://doi.org/10.1074/jbc.M108545200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11777908"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11777908"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Soonyean Hwang, Hye-Eun Kim, Michelle Min, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jid.2015.160"}], "href": "https://doi.org/10.1038/jid.2015.160"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25910030"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25910030"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Dongli Yue, Qingxia Fan, Xinfeng Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2013.11.009"}], "href": "https://doi.org/10.1016/j.yexcr.2013.11.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24269829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24269829"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Matthew B Seefeldt, Jun Ouyang, Wayne A Froland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High-pressure refolding of bikunin: efficacy and thermodynamics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Protein Sci (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1110/ps.04891204"}], "href": "https://doi.org/10.1110/ps.04891204"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15388859"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15388859"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Eva Maurer, Michael Gütschow, Marit Stirnberg "}, {"type": "b", "children": [{"type": "t", "text": "Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20121518"}], "href": "https://doi.org/10.1042/BJ20121518"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23293962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23293962"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Nicolas Faller, Ivan Gautschi, Laurent Schild "}, {"type": "b", "children": [{"type": "t", "text": "Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0094267"}], "href": "https://doi.org/10.1371/journal.pone.0094267"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24722141"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24722141"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Edmund Kwok-Kwan Tung, Chun-Ming Wong, Tai-On Yau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.24115"}], "href": "https://doi.org/10.1002/ijc.24115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19107935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19107935"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Lasse Holt-Danborg, Julia Vodopiutz, Annika W Nonboe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SPINT2 (HAI-2) missense variants identified in congenital sodium diarrhea/tufting enteropathy affect the ability of HAI-2 to inhibit prostasin but not matriptase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddy394"}], "href": "https://doi.org/10.1093/hmg/ddy394"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30445423"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30445423"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Andrew S Murray, Fausto A Varela, Thomas E Hyland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M117.775999"}], "href": "https://doi.org/10.1074/jbc.M117.775999"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28710277"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28710277"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "K Nakamura, F Abarzua, A Hongo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdn556"}], "href": "https://doi.org/10.1093/annonc/mdn556"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18689863"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18689863"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Annika W Nonboe, Oliver Krigslund, Christoffer Soendergaard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Traffic (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/tra.12482"}], "href": "https://doi.org/10.1111/tra.12482"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28371047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28371047"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Hsiang-Hua D Chang, Yuan Xu, Hongyu Lai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0120489"}], "href": "https://doi.org/10.1371/journal.pone.0120489"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25786220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25786220"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Shiao-Pieng Lee, Chen-Yu Kao, Shun-Cheng Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0192632"}], "href": "https://doi.org/10.1371/journal.pone.0192632"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29438412"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29438412"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Marco R Straus, Jonathan T Kinder, Michal Segall, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virology (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.virol.2020.01.004"}], "href": "https://doi.org/10.1016/j.virol.2020.01.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32056846"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32056846"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Masamichi Yamauchi, Hiroshi Itoh, Seiji Naganuma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/BC.2002.220"}], "href": "https://doi.org/10.1515/BC.2002.220"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12553733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12553733"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Osamu Nagakawa, Toshiya Yamagishi, Takuya Akashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum hepatocyte growth factor activator inhibitor type I (HAI-I) and type 2 (HAI-2) in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pros.20301"}], "href": "https://doi.org/10.1002/pros.20301"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16353247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16353247"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Shang-Ru Wu, Chen-Hsin Teng, Ya-Ting Tu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-15415-4"}], "href": "https://doi.org/10.1038/s41598-017-15415-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29118397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29118397"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Maria d'Apolito, Daniela Pisanelli, Flavio Faletra, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic analysis of Italian patients with congenital tufting enteropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Pediatr (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12519-015-0070-y"}], "href": "https://doi.org/10.1007/s12519-015-0070-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26684320"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26684320"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Fernanda Marconi Roversi, Nathalia Moreno Cury, Matheus Rodrigues Lopes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.14066"}], "href": "https://doi.org/10.1111/jcmm.14066"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30484958"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30484958"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Shang-Ru Wu, Chia-Hao Lin, Han-Po Shih, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41416-019-0400-2"}], "href": "https://doi.org/10.1038/s41416-019-0400-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30765871"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30765871"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Kristin E Hirabayashi, Anthony T Moore, Bryce A Mendelsohn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Congenital sodium diarrhea and chorioretinal coloboma with optic disc coloboma in a patient with biallelic SPINT2 mutations, including p.(Tyr163Cys)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.38637"}], "href": "https://doi.org/10.1002/ajmg.a.38637"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29575628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29575628"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Sara Vanessa Bernhard, Katarzyna Seget-Trzensiok, Christian Kuffer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Oncol (Dordr) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13402-021-00654-5"}], "href": "https://doi.org/10.1007/s13402-021-00654-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34962618"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34962618"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Márcia Santos Pereira, Sónia Pires Celeiro, Ângela Margarida Costa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Oncol (Dordr) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13402-019-00475-7"}], "href": "https://doi.org/10.1007/s13402-019-00475-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31701492"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31701492"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Márcia Santos Pereira, Gisele Caravina de Almeida, Filipe Pinto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SPINT2 Deregulation in Prostate Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Histochem Cytochem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1369/0022155415612874"}], "href": "https://doi.org/10.1369/0022155415612874"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26442953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26442953"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Ciara N Murphy, Susan P Walker, Teresa M MacDonald, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated Circulating and Placental SPINT2 Is Associated with Placental Dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22147467"}], "href": "https://doi.org/10.3390/ijms22147467"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34299087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34299087"}]}]}]}
|
| Synonyms | KOP, HAI-2, HAI2, DIAR3, PB |
| Proteins | SPIT2_HUMAN |
| NCBI Gene ID | 10653 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SPINT2 has 8,609 functional associations with biological entities spanning 9 categories (molecular profile, organism, disease, phenotype or trait, functional term, phrase or reference, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 115 datasets.
Click the + buttons to view associations for SPINT2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SPINT2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SPINT2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SPINT2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SPINT2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SPINT2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SPINT2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SPINT2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SPINT2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SPINT2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SPINT2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SPINT2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SPINT2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SPINT2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SPINT2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SPINT2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with SPINT2 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with SPINT2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing SPINT2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SPINT2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SPINT2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SPINT2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SPINT2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SPINT2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SPINT2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SPINT2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with SPINT2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SPINT2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SPINT2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SPINT2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SPINT2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SPINT2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SPINT2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SPINT2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SPINT2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SPINT2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SPINT2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SPINT2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SPINT2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SPINT2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SPINT2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SPINT2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SPINT2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SPINT2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SPINT2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SPINT2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SPINT2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding SPINT2 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SPINT2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SPINT2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SPINT2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SPINT2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SPINT2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SPINT2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SPINT2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SPINT2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SPINT2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SPINT2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SPINT2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SPINT2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SPINT2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SPINT2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SPINT2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SPINT2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SPINT2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SPINT2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SPINT2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SPINT2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with SPINT2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SPINT2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SPINT2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SPINT2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SPINT2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SPINT2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SPINT2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SPINT2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SPINT2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SPINT2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SPINT2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SPINT2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SPINT2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SPINT2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SPINT2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SPINT2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SPINT2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SPINT2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SPINT2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with SPINT2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SPINT2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SPINT2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SPINT2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SPINT2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SPINT2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving SPINT2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SPINT2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SPINT2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SPINT2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SPINT2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SPINT2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SPINT2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SPINT2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with SPINT2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SPINT2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of SPINT2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SPINT2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SPINT2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SPINT2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SPINT2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SPINT2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SPINT2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SPINT2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SPINT2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SPINT2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SPINT2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| Virus MINT Protein-Viral Protein Interactions | interacting viral proteins for SPINT2 from the Virus MINT Protein-Viral Protein Interactions dataset. | |
| Virus MINT Protein-Virus Interactions | viruses interacting with SPINT2 from the Virus MINT Protein-Virus Interactions dataset. | |